Temozolomide in the Treatment of Advanced Non-Small Cell Lung Carcinoma: Phase II Evaluation in Previously Treated and Chemo-Naive Patients
Phase of Trial: Phase II
Latest Information Update: 28 Jan 2013
At a glance
- Drugs Temozolomide (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 16 Feb 2010 Actual end date (Apr 2008) added as reported by ClinicalTrials.gov.
- 16 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Oct 2005 New trial record.